drugset / Trial / NCT00235859

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859

Phase 3 Completed 128 enrolled Abbott Eisai Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to assess the safety and efficacy of adalimumab compared to placebo in subjects with rheumatoid arthritis on methotrexate therapy.

Timeline

Start
2003-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Adalimumab Monoclonal antibody Subcutaneous
Background Methotrexate Small molecule

Indications